Yoav Nir

MediCane Health, Inc. is an Israeli international pharmaceutical company that specializes in the research, development, production, and marketing of cannabis-based medications. The company is based in Kfar Saba, Israel. Its subsidiaries, M.H MediCane Ltd. and MediCane R&D Ltd., develop medical cannabis and pharmaceutical products derived from synthetic and isolated cannabis molecules in three therapeutic areas: dementia, insomnia, and irritable bowel syndrome. The company's R&D activities are carried out in-house by its experienced team and through collaboration with world-renowned scientists and leading research institutions. MediCane Health has operational subsidiaries in various countries and a commercial hub. The company was founded by Yossi Ben Amram and Hagai Greenspoon, and Yossi Ben Amram has been the CEO since incorporation.

MediCane Health, Inc. is an Israeli international pharmaceutical company that specializes in the research, development, production, and marketing of cannabis-based medications. The company is based in Kfar Saba, Israel. Its subsidiaries, M.H MediCane Ltd. and MediCane R&D Ltd., develop medical cannabis and pharmaceutical products derived from synthetic and isolated cannabis molecules in three therapeutic areas: dementia, insomnia, and irritable bowel syndrome. The company's R&D activities are carried out in-house by its experienced team and through collaboration with world-renowned scientists and leading research institutions. MediCane Health has operational subsidiaries in various countries and a commercial hub. The company was founded by Yossi Ben Amram and Hagai Greenspoon, and Yossi Ben Amram has been the CEO since incorporation.

MediCane Health, Inc. is an Israeli international pharmaceutical company that specializes in the research, development, production, and marketing of cannabis-based medications. The company is based in Kfar Saba, Israel. Its subsidiaries, M.H MediCane Ltd. and MediCane R&D Ltd., develop medical cannabis and pharmaceutical products derived from synthetic and isolated cannabis molecules in three therapeutic areas: dementia, insomnia, and irritable bowel syndrome. The company's R&D activities are carried out in-house by its experienced team and through collaboration with world-renowned scientists and leading research institutions. MediCane Health has operational subsidiaries in various countries and a commercial hub. The company was founded by Yossi Ben Amram and Hagai Greenspoon, and Yossi Ben Amram has been the CEO since incorporation.